4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
MedinCell S.A. (MEDCL) operates in the Biotechnology industry and is headquartered in Jacou, France with about 141 employees. Its market capitalization is roughly €865 million. In the fiscal year ended 2026-03-31, MEDCL reported €20M in revenue and (€31M) in net income.
MedinCell S.A., a clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France. The company develops solutions based on BEPO, a long-acting injectable technology.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | €20M | €26M | €9M | €10M | — |
| Gross Profit | €20M | €26M | €9M | €10M | — |
| Operating Income (EBIT) | (€21M) | (€11M) | (€21M) | (€24M) | — |
| Net Income | (€31M) | (€18M) | (€25M) | (€32M) | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | €108M | €90M | €37M | €29M | — |
| Total Liabilities | €105M | €107M | €78M | €72M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MEDCL viewer.
About TickerBase · Data methodology & sources · Privacy · Terms